Adverse Events for Overactive Bladder Medications From a Public Federal Database.
Christina SzeSiri DrangsholtMichelina D StoddardZorawar SinghStephanie SansoneNaeem BhojaniKevin ZornDean EltermanBilal Chughtai
Published in: Female pelvic medicine & reconstructive surgery (2022)
The FAERS database not only is a repository of ADEs but also may represent evolving prescribing habits for OAB medications. Transdermal oxybutynin had the lowest NP ADEs and may be appropriate for selected individuals.